Small fiber neuropathy (SFN) is a condition where the smallest nerve fibers in your body become damaged, causing burning pain, tingling, and problems with automatic body functions like sweating and heart rate. Unlike more familiar forms of nerve damage that affect movement and reflexes, SFN targets only the thin nerve fibers in your skin and organs, which makes it harder to detect on standard neurological exams. A 2024 Dutch population study estimated the prevalence at roughly 70 per 100,000 adults, with women affected at nearly twice the rate of men.
Which Nerves Are Affected
Your nervous system contains fibers of different sizes, and each size handles different jobs. The large fibers control muscle movement and carry signals about vibration and joint position. The small fibers, called A-delta and C-fibers, handle a different set of tasks: detecting pain, temperature, and itch in the skin. They also regulate nearly all involuntary body functions, including heart rate, blood pressure, digestion, bladder control, and body temperature.
In SFN, only these small fibers are damaged. Because large fibers remain intact, your muscle strength, reflexes, and balance stay normal. This is a key distinction. Someone with SFN can walk fine and grip objects without trouble, yet experience severe burning pain in their feet. The exact mechanism of damage isn’t fully understood, but reduced blood flow to nerves, inflammatory molecules, and oxidative stress all appear to play roles.
What It Feels Like
The most common early symptoms are a burning sensation or “pins and needles” pain in the hands and feet. This pain often starts in the feet and can spread upward over time. Some people describe it as walking on glass or feeling sunburned skin without any visible redness. The discomfort tends to worsen at night or after standing for long periods.
Beyond pain, SFN can cause numbness or patches where you can’t feel temperature or pain normally. This creates an odd paradox: you might have intense burning in one area while being unable to detect heat in a nearby spot.
The autonomic symptoms are what catch many people off guard, because they seem unrelated to nerve damage. These include:
- Lightheadedness or fainting from blood pressure that doesn’t adjust properly when you stand
- Heart palpitations or abnormal heart rate changes
- Excessive or reduced sweating
- Stomach cramps and digestive problems
- Bladder dysfunction
Not everyone experiences all of these. Some people have mostly pain, others deal primarily with autonomic issues, and many have a mix of both.
Common Causes
Diabetes and prediabetes are the most frequently identified triggers. Chronically elevated blood sugar damages small nerve fibers over time, and this damage can begin even before someone receives a formal diabetes diagnosis. Autoimmune conditions, including Sjögren’s syndrome, lupus, and celiac disease, account for another significant group. Some cases trace back to genetic mutations affecting sodium channels in nerve cells, which cause the fibers to misfire or degenerate.
Other recognized causes include vitamin B12 deficiency, excessive alcohol use, certain chemotherapy drugs, HIV, and thyroid disorders. In a substantial number of cases, no underlying cause is ever found. These are classified as idiopathic SFN, and they represent a frustrating reality for many patients who go through extensive testing without a clear answer.
How It Differs From Other Neuropathy
Large fiber neuropathy, the type most people picture when they hear “neuropathy,” causes weakness, loss of reflexes, difficulty with balance, and reduced ability to feel vibration. It shows up clearly on standard nerve conduction studies, which measure how fast electrical signals travel through large nerve fibers. SFN doesn’t. Routine neurological exams and nerve conduction tests can come back completely normal in someone with significant small fiber damage, which is why the condition is often missed or dismissed early on.
This diagnostic gap is one of the most frustrating aspects of SFN. Patients may see multiple doctors and receive normal test results before getting the right workup. The condition requires specialized testing that not every clinic offers.
About 13% to 36% of SFN cases eventually progress to involve large fibers as well. But for many patients, the condition follows a slowly progressive course that reaches a plateau lasting years. In one study, over half of patients either improved or stayed stable over a two-year follow-up period.
How It’s Diagnosed
The gold standard is a skin punch biopsy, a quick procedure where a doctor removes a tiny round sample of skin (usually from the lower leg and sometimes the thigh) and sends it to a lab. Technicians count the number of nerve fiber endings that penetrate the outer layer of skin, called the intraepidermal nerve fiber density. Normal density at the lower leg averages about 13.8 fibers per millimeter. If your count falls below the 5th percentile for your age and sex (roughly 3.8 per millimeter at the lower leg), SFN is confirmed. This test is highly specific, correctly identifying normal results about 97% of the time, but it isn’t available at every medical center.
Another useful test is the quantitative sudomotor axon reflex test, or QSART, which evaluates the small nerve fibers that control sweating. A mild electrical stimulus is applied to the skin, and a device measures how much sweat your body produces and how long it takes to start sweating. Delayed onset or abnormal sweat volume points to small fiber dysfunction. This test is particularly helpful when autonomic symptoms are prominent.
Blood work is also part of the diagnostic process, not to confirm SFN itself, but to identify an underlying cause. This typically includes blood sugar and hemoglobin A1c levels, vitamin B12, thyroid function, and markers for autoimmune disease.
Treatment and Pain Management
The most important step is treating the underlying cause when one is identified. Bringing blood sugar under control in diabetic SFN, for example, can slow further nerve damage and sometimes allow partial nerve regrowth. Correcting a B12 deficiency or managing an autoimmune condition addresses the root problem rather than just masking symptoms.
For pain relief, neuropathic pain guidelines recommend several first-line medication categories: anticonvulsants like gabapentin and pregabalin, which calm overactive nerve signals; certain antidepressants that also dampen pain pathways, including duloxetine and venlafaxine; and older tricyclic antidepressants. These medications weren’t designed specifically for nerve pain, but they target the same signaling systems that small fibers use, which is why they help. Finding the right one often takes trial and error, and many people try more than one before landing on an effective option.
Topical treatments like lidocaine patches and capsaicin cream offer a second-line option, particularly for localized pain. They work directly at the skin surface without the systemic side effects of oral medications. For people with genetic forms of SFN linked to sodium channel mutations, newer anticonvulsants that specifically block sodium channels are showing promise.
Non-drug approaches also play a meaningful role. Regular exercise and dietary changes have shown benefits for neuropathic pain and autonomic symptoms, especially in patients with diabetes, HIV, or chemotherapy-related nerve damage. Cognitive behavioral therapy and mindfulness practices have mixed evidence for nerve pain on their own but can be helpful alongside medication, particularly for managing the sleep disruption and emotional toll of chronic pain.
Living With SFN
Many people with SFN find that symptoms fluctuate. Heat, prolonged standing, stress, and alcohol can all worsen pain and autonomic symptoms on a given day. Cooling the feet, wearing loose socks, and avoiding prolonged heat exposure are simple strategies that provide some relief. For those with blood pressure regulation problems, compression garments, increased salt intake (when medically appropriate), and standing up slowly can reduce lightheadedness.
The trajectory varies widely. Some people experience a stable, manageable condition for years. Others see gradual worsening, particularly if the underlying cause remains untreated. The fact that over half of patients in clinical follow-up either improve or hold steady is a meaningful data point for anyone newly diagnosed and worried about what comes next.